Hybrid High-Dose Bolus/Continuous Infusion Interleukin-2 in Patients with Metastatic Renal Cell Carcinoma: A Phase II Trial of the National Biotherapy Study Group-Reference-Cited by-同舟云学术

Hybrid High-Dose Bolus/Continuous Infusion Interleukin-2 in Patients with Metastatic Renal Cell Carcinoma: A Phase II Trial of the National Biotherapy Study Group

Published:1997-02 Issue:1 Volume:12 Page:5-11
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Dillman Robert O.,Wiemann Michael C.,Bury Martin J.,Church Curtis,DePriest Carol

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.1997.12.5

Reference24 articles.

1. Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.

2. Comparison of Carbamazepine, Phenobarbital, Phenytoin, and Primidone in Partial and Secondarily Generalized Tonic–Clonic Seizures

3. Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced Cancer

4. High-Dose Recombinant Interleukin-2 Alone: A Regimen With Limited Activity in the Treatment of Advanced Renal Cell Carcinoma

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Should High-Dose Interleukin-2 Still be the Preferred Treatment for Patients with Metastatic Renal Cell Cancer?;Cancer Biotherapy and Radiopharmaceuticals;2011-06

2. Cancer Immunotherapy;Cancer Biotherapy and Radiopharmaceuticals;2011-02

3. Metastatic Kidney Cancer: Treatment with Infusional Interleukin-2 Plus Famotidine;Methods of Cancer Diagnosis, Therapy, and Prognosis;2009-10-10

4. High-Dose Intensity Pulse Interleukin-2 with Famotidine in Metastatic Kidney Cancer;Cancer Biotherapy and Radiopharmaceuticals;2009-04

5. High-Dose Intensity Pulse Interleukin-2 with Famotidine Has Activity in Metastatic Melanoma;Cancer Biotherapy and Radiopharmaceuticals;2008-10